Related Experiment Video
Updated: Dec 17, 2025
08:15
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
839
Ephedrine causes retinal damage in SD rats associating with JAK2/STAT3 pathway
1Department of Ophthalmology, Beijing China-Japan Friendship Hospital, Beijing, People's Republic of China.
Cutaneous and Ocular Toxicology
|July 1, 2020
Summary
Ephedrine causes retinal damage by inducing apoptosis and oxidative stress. This may be linked to the down-regulation of the JAK2/STAT3 pathway in Sprague Dawley rats.
Area of Science:
- Ophthalmology
- Toxicology
- Neuroscience
Background:
- Ephedrine is known to cause cardiovascular and nervous system side effects.
- The specific cellular mechanisms of ephedrine toxicity, particularly in the retina, are not well understood.
Purpose of the Study:
- To investigate the effects of ephedrine on retinal tissue.
- To explore the underlying cellular mechanisms of ephedrine-induced retinal toxicity.
Main Methods:
- Sprague Dawley rats were administered ephedrine or saline daily for seven days.
- Retinal morphology was assessed using Toluidine blue staining.
- Apoptosis markers, neurotransmitters, oxidative stress markers, and JAK2/STAT3 pathway components (gene and protein expression) were analyzed.
Main Results:
- Ephedrine treatment led to significant retinal apoptosis.
- Dopamine levels and oxidative stress markers were elevated in ephedrine-treated rats.
- Ephedrine down-regulated the expression of JAK2/STAT3 genes and proteins (p-JAK2/p-STAT3).
Conclusions:
- Ephedrine administration causes retinal damage in Sprague Dawley rats.
- The observed retinal damage may be associated with the inhibition of the JAK2/STAT3 signaling pathway.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
11.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.3K
01:28Adrenergic Agonists: Mixed-Action Agents
1.3K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.3K